Quent Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Quent Capital’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08K	Buy	+32	New	+$1.07K	﹤0.01%	1539
2023 Q4	–	Sell	-500	Closed	-$5.1K	–	1351
2023 Q3	$5.1K	Hold	500	–	–	﹤0.01%	1046
2023 Q2	$3.77K	Hold	500	–	–	﹤0.01%	1095
2023 Q1	$4.42K	Hold	500	–	–	﹤0.01%	1063
2022 Q4	$4.56K	Hold	500	–	–	﹤0.01%	1027
2022 Q3	$4K	Hold	500	–	–	﹤0.01%	1018
2022 Q2	$4K	Sell	500 -166	-25%	-$1.45K	﹤0.01%	995
2022 Q1	$6K	Hold	666	–	–	﹤0.01%	1020
2021 Q4	$5K	Buy	+666	New	+$6.01K	﹤0.01%	931

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Quent Capital's TEVA Position: Q2 2026 in Review

Quent Capital opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 32 shares worth $1.08K. The stake represents ﹤0.01% of the portfolio and ranks #1539 among its holdings. This is a return to the name: Quent Capital previously reported a position in TEVA as recently as Q3 2023.

Quent Capital first reported a position in TEVA in Q4 2021 and has held it in 9 quarters since. The position peaked at $6K in Q1 2022. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Quent Capital held 32 shares of Teva Pharmaceuticals worth $1.08K as of Q2 2026.
Teva Pharmaceuticals was a new Quent Capital position in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1539 holding.
Quent Capital first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 9 quarters since.
Quent Capital's Teva Pharmaceuticals position peaked at $6K in Q1 2022.
675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.